Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters











Database
Language
Publication year range
1.
Am J Pathol ; 168(1): 20-32, 2006 Jan.
Article in English | MEDLINE | ID: mdl-16400006

ABSTRACT

Podocytes are crucial for the permeability of the glomerular filtration barrier. In glomerular disease, however, reactive oxygen species (ROS) may be involved in podocyte injury and subsequent proteinuria. Here, we describe ROS-dependent gene induction in differentiated podocytes stimulated with H(2)O(2) or xanthine/xanthine-oxidase. Superoxide anions and H(2)O(2) increased mRNA and protein expression of GAS5 (growth arrest-specific protein 5) and CHOP (C/EBP homology protein). Cultured podocytes overexpressing CHOP showed increased generation of superoxide anions compared to controls. In addition, the expression of alpha(3)/beta(1) integrins, crucial for cell-matrix interaction of podocytes, was down-regulated, leading to increased cell-matrix adhesion and cell displacement. The altered cell-matrix adhesion was antagonized by the ROS scavenger 1,3-dimethyl-2-thiourea, and the increase in cell displacement could be mimicked by stimulating untransfected podocytes with puromycin, an inductor of ROS. We next performed immunohistochemical staining of human kidney tissue (normal, membranous nephropathy, focal segmental glomerulosclerosis, and minimal change nephropathy) as well as sections from rats with puromycin nephrosis, a model of minimal change nephropathy. CHOP was weakly expressed in podocytes of control kidneys but up-regulated in most proteinuric human kidneys and in rat puromycin nephrosis. Our data suggest that CHOP-via increased ROS generation-regulates cell-matrix adhesion of podocytes in glomerular disease.


Subject(s)
Podocytes/metabolism , Reactive Oxygen Species/pharmacology , Transcription Factor CHOP/metabolism , Animals , Blotting, Western , Cell Adhesion/drug effects , Cell Adhesion/physiology , Cells, Cultured , Disease Models, Animal , Down-Regulation , Free Radical Scavengers/pharmacology , Gene Expression/drug effects , Humans , Hydrogen Peroxide/metabolism , Hydrogen Peroxide/pharmacology , Immunohistochemistry , Integrin alpha Chains/drug effects , Integrin alpha Chains/metabolism , Integrin beta Chains/drug effects , Integrin beta Chains/metabolism , Kidney Diseases/metabolism , Mice , Podocytes/drug effects , Polymerase Chain Reaction , RNA, Messenger/analysis , RNA, Small Nucleolar/drug effects , RNA, Small Nucleolar/metabolism , Rats , Reactive Oxygen Species/metabolism , Superoxides/metabolism , Superoxides/pharmacology , Transcription Factor CHOP/drug effects
2.
Nephrol Dial Transplant ; 17(10): 1742-50, 2002 Oct.
Article in English | MEDLINE | ID: mdl-12270979

ABSTRACT

BACKGROUND: Knowledge about Ca(2+) extrusion mechanisms in podocytes is limited. The aim of the study was to test whether a Na(+)-Ca(2+) exchanger (NCX) is present in differentiated podocytes and if so to examine its regulatory properties. METHODS: Intracellular Ca(2+) concentration ([Ca(2+)](i)) and intracellular pH were measured microspectrofluorometrically in single podocytes. Expression of NCX mRNA was studied by reverse transcription-polymerase chain reaction. NCX protein expression was investigated by immunocytochemistry. RESULTS: Substitution of extracellular Na(+) (from 145 to 0, 5, 10, 20, and 30 mM) with N-methyl-D-glucamine resulted in a Na(+) concentration-dependent, reversible increase of [Ca(2+)](i). Complete extracellular Na(+) substitution (0 Na(+)) increased [Ca(2+)](i) reversibly from 95+/-5 to 275+/-16 and back to 66+/-5 nM (n=205). Raising the intracellular Na(+) concentration by application of 50 micro M monensin increased [Ca(2+)](i) from 105+/-22 to 192+/-45 nM (n=12). The [Ca(2+)](i) response induced by a low Na(+) concentration required extracellular Ca(2+) and did not correlate with changes of intracellular pH. The effect was blocked by the NCX inhibitor benzamil (IC(50) approximately 100 nM). Neither flufenamate (100 micro M, n=6), a blocker of non-selective cation channels, nor Hoe 694 (1 micro M, n=6), an inhibitor of the Na(+)-H(+) exchanger, did significantly influence the [Ca(2+)](i) response induced by extracellular Na(+) depletion. Activation of protein kinase C (PKC) by short-term application (5 min) of phorbol 12-myristate-13-acetate (PMA; 10 nM, n=4; 100 nM, n=7) inhibited Na(+)-Ca(2+) exchange, whereas PKC inhibition by long-term incubation (24 h) with PMA (100 nM, n=9) or bisindolylmaleimide I (100 nM, n=11) both increased Na(+)-Ca(2+) exchange, respectively. Expression of NCX mRNA was detected both in cultured differentiated podocytes and in podocytes directly pulled off from glomeruli ex vivo. NCX protein expression was detected by immunocytochemistry. In a different series of experiments, we studied the potential involvement of the exchanger in podocyte injury induced by the aminonucleoside puromycin. Pre-treatment of podocytes with 0.3 mM puromycin for 24 h significantly reduced the [Ca(2+)](i) response induced by extracellular Na(+) depletion (n=56). Compared with mRNA expression of the housekeeping gene GAPDH, NCX mRNA expression was significantly reduced by puromycin. CONCLUSION: Our results demonstrate the presence of a Na(+)-Ca(2+) exchanger in podocytes and its regulation by PKC. Inhibition of Na(+)-Ca(2+) exchange by puromycin may contribute to podocyte injury in PAN nephrosis.


Subject(s)
Amiloride/analogs & derivatives , Kidney/cytology , Kidney/metabolism , Sodium-Calcium Exchanger/metabolism , Amiloride/pharmacology , Animals , Calcium/metabolism , Cells, Cultured , Cytosol/metabolism , Enzyme Activation/physiology , Extracellular Space/metabolism , Hydrogen-Ion Concentration , Mice , Osmolar Concentration , Protein Kinase C/metabolism , Puromycin Aminonucleoside/pharmacology , RNA, Messenger/metabolism , Sodium/metabolism , Sodium-Calcium Exchanger/antagonists & inhibitors , Sodium-Calcium Exchanger/drug effects , Sodium-Calcium Exchanger/genetics
3.
J Am Soc Nephrol ; 13(1): 86-95, 2002 Jan.
Article in English | MEDLINE | ID: mdl-11752025

ABSTRACT

It has been suggested that reactive oxygen radicals (ROS) play a crucial role in the pathogenesis of proteinuria and podocyte injury. It was investigated whether changes in gene expression might account for ROS-induced podocyte dysfunction. Differentiated podocytes were incubated with control media or with exogenous ROS from the xanthine/xanthine-oxidase reaction for 4 h. A PCR-based suppressive subtractive hybridization assay was applied to isolate and clone mRNAs that were differentially expressed by exogenous ROS. One differentially expressed clone was identified as the proinflammatory cytokine granulocyte macrophage-colony-stimulating factor (GM-CSF). Regulation of GM-CSF in podocytes was further studied by Northern analysis and enzyme-linked immunosorbent assay. Exogenous ROS caused a concentration-dependent, >10-fold induction of GM-CSF mRNA after 4 h. A >50-fold increase in GM-CSF protein release in podocytes that had been stimulated with ROS could be detected. Induction of GM-CSF protein was inhibited by actinomycin D, which indicated that increased mRNA transcription was involved. The ROS scavengers dimethyl-thio-urea and pyrrolidone-dithio-carbamate strongly inhibited increased GM-CSF production induced by ROS. GM-CSF release was also induced when internal ROS production was triggered with NADH, whereas H2O2 had only a small effect. GM-CSF release by podocytes was also stimulated by lipopolysaccharide (LPS), interleukin-1 (IL-1), and phorbolester (PMA). Dimethyl-thio-urea significantly inhibited the LPS-, IL-1-, and PMA-induced GM-CSF production. Activation of the transcription factor nuclear factor-kappaB (NF-kappaB) but not activator protein-1 was involved in the upregulation of ROS-induced GM-CSF production. The data indicate that GM-CSF is differentially expressed by ROS in podocytes. ROS also partially mediate the effects of PMA and IL-1 on podocyte GM-CSF production. Because GM-CSF can enhance glomerular inflammation and induces mesangial proliferation, these data might provide further insight into the mechanisms of ROS-induced glomerular injury.


Subject(s)
Gene Expression Regulation/physiology , Gene Expression/physiology , Granulocyte-Macrophage Colony-Stimulating Factor/genetics , Kidney/physiology , Reactive Oxygen Species/metabolism , Thiourea/analogs & derivatives , Animals , Cells, Cultured , Free Radical Scavengers/pharmacology , Gene Expression Regulation/drug effects , Granulocyte-Macrophage Colony-Stimulating Factor/metabolism , Interleukin-1/pharmacology , Kidney/cytology , Lipopolysaccharides/pharmacology , Mice , NF-kappa B/physiology , Pyrrolidines/pharmacology , RNA, Messenger/metabolism , Reactive Oxygen Species/pharmacology , Tetradecanoylphorbol Acetate/pharmacology , Thiocarbamates/pharmacology , Thiourea/pharmacology , Time Factors , Transcription, Genetic/physiology , Up-Regulation , Xanthine/metabolism , Xanthine Oxidase/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL